GST-HG141: Clinical Trials

2 trials of GST-HG141, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Recruiting 1

Follow GST-HG141: new trials by email Literature Review of GST-HG141 trials Research Report on GST-HG141

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of GST-HG131&141 Tablets Compared With Placebo in Patients With Chronic Hepatitis B
GST-HG141, GST-HG131, GST-HG141 Placebo - Chronic Hepatitis B
Phase 2RecruitingFujian Akeylink Biotechnology Co., Ltd.802026-07-102026-07-17
Evaluation of The Safety, Efficacy and Pharmacokinetic Characteristics of GST-HG141 Tablets
GST-HG141 - Chronic Hepatitis b
Phase 2CompletedFujian Akeylink Biotechnology Co., Ltd.902023-01-032025-03-05

Conditions studied

Hepatitis B, Chronic (2)

Sponsors

Fujian Akeylink Biotechnology Co., Ltd. (2)

Countries

China (2)

Results publications

PMID 40808966